Unknown

Dataset Information

A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial.


ABSTRACT:

SUBMITTER: Chang-Monteagudo A 

PROVIDER: S-EPMC8442527 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature